Dr. Jang on current state of immunotherapy in advanced GU cancers

The study showed significant reductions in both anxiety and depressive symptoms following the intervention.

“When you compound the patient delay and…the physician delay, then you really get a delay in diagnosis,” says Curtis A. Pettaway, MD.

Investigators observed promising clinical effect with the EGFR / HER3 bispecific antibody-drug conjugate.

“Because so many disease processes that we deal with are related to tobacco use and smoking specifically… I think this is absolutely our domain,” says Richard S. Matulewicz, MD, of tobacco cessation counseling and treatment.

"I think the micronized formulation is something to think about," says Gautam Jayram, MD.

The cisplatin drug shortage was first announced on February 10, 2023.